Mitochondria: A Therapeutic Target for Parkinson's Disease?

International Journal of Molecular Sciences
Yu LuoXin Qi

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The exact causes of neuronal damage are unknown, but mounting evidence indicates that mitochondrial-mediated pathways contribute to the underlying mechanisms of dopaminergic neuronal cell death both in PD patients and in PD animal models. Mitochondria are organized in a highly dynamic tubular network that is continuously reshaped by opposing processes of fusion and fission. Defects in either fusion or fission, leading to mitochondrial fragmentation, limit mitochondrial motility, decrease energy production and increase oxidative stress, thereby promoting cell dysfunction and death. Thus, the regulation of mitochondrial dynamics processes, such as fusion, fission and mitophagy, represents important mechanisms controlling neuronal cell fate. In this review, we summarize some of the recent evidence supporting that impairment of mitochondrial dynamics, mitophagy and mitochondrial import occurs in cellular and animal PD models and disruption of these processes is a contributing mechanism to cell death in dopaminergic neurons. We also summarize mitochondria-targeting therapeutics in models of PD, proposing that modulation of mitochondrial impairment might ...Continue Reading

References

Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·H YoshinoY Mizuno
Jul 1, 1992·Acta Neurologica Scandinavica·T H Caradoc-DaviesP Hantz
May 11, 1992·Annals of the New York Academy of Sciences·R C Duvoisin
Mar 1, 1990·Annals of Neurology·L I GolbeR C Duvoisin
Aug 16, 1990·Biochemical and Biophysical Research Communications·S IkebeT Ozawa
Jun 1, 1986·The American Journal of Psychiatry·R MayeuxI Dyrenfurth
Feb 22, 1986·British Medical Journal·W J MutchS K Roy
Aug 4, 1983·The New England Journal of Medicine·J W Langston, P A Ballard
Dec 1, 1994·Annals of Neurology·V M MannA H Schapira
Nov 15, 1996·Science·M H PolymeropoulosR C Duvoisin
Apr 11, 1997·Science·R H ZetterströmT Perlmann
Mar 1, 1997·Experimental Neurology·W J BowersH J Federoff
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·M P SmidtJ P Burbach
Feb 6, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·F BlandiniJ T Greenamyre
Sep 28, 1998·Annals of Neurology·P Jenner, C W Olanow
Oct 30, 1998·Molecular Medicine Today·O RiessR Krüger
Dec 10, 1999·Experimental Cell Research·A WallénT Perlmann
May 29, 2000·Current Opinion in Genetics & Development·H R de SilvaN W Wood
Aug 26, 2000·Current Opinion in Chemical Biology·R G Smith
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F Dabbeni-SalaP Giusti
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael K LeeDon L Price
Dec 20, 2002·Human Molecular Genetics·Clotilde LevecqueMarie-Christine Chartier-Harlin
Jan 14, 2003·Annual Review of Physiology·Christopher D Moyes, David A Hood
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Irene NunesStephen P Goff
Jun 14, 2003·Brain : a Journal of Neurology·M C J DekkerC M van Duijn
Jul 9, 2003·Annals of the New York Academy of Sciences·Asa Wallén, Thomas Perlmann
Jul 9, 2003·Annals of the New York Academy of Sciences·J Peter H BurbachMarten P Smidt
Aug 22, 2003·The Journal of Biological Chemistry·Matthew S GoldbergJie Shen
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Oct 24, 2003·Molecular and Cellular Neurosciences·Suzana GispertRobert L Nussbaum
Nov 1, 2003·Science·Ted M Dawson, Valina L Dawson

❮ Previous
Next ❯

Citations

May 18, 2016·International Journal of Molecular Sciences·Giuseppe Coppotelli, Jaime M Ross
Apr 4, 2017·Mitochondrion·Evy LefevereInge Van Hove
Nov 27, 2018·Translational Neuroscience·Jianying HeWeiyan Hu
Nov 5, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Md Ezazul HaqueDong-Kug Choi
Dec 12, 2019·Neurotoxicity Research·Saumitra Sen SinghSurya Pratap Singh
Dec 22, 2016·International Journal of Molecular Medicine·Noriko NakanoYasuko Kitagishi
Mar 16, 2018·Frontiers in Molecular Neuroscience·Maria Perez CarrionGiovanni Piccoli
Apr 29, 2018·Scientific Reports·Reetta J HolmilaCristina M Furdui
Jul 2, 2020·Cells·Maria Sebastian-Valverde, Giulio M Pasinetti
Dec 7, 2016·Frontiers in Aging Neuroscience·Hayley D Ackerman, Glenn S Gerhard
Oct 17, 2018·Frontiers in Behavioral Neuroscience·Chang-Wei WeiAn-Shi Wu
Jun 24, 2018·International Journal of Molecular Sciences·Alessia FabbriCarla Fiorentini
Sep 30, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ramandeep KaurShamsher Singh
Jun 7, 2016·Journal of Neuroscience Research·Kyung Moon LeeJaewon Lee
Aug 1, 2020·Oxidative Medicine and Cellular Longevity·Jian-Kang MuXing-Xin Yang
Nov 13, 2020·Molecular Neurobiology·Shweta Goyal, Rajnish Kumar Chaturvedi
Jan 3, 2021·Brain Research Bulletin·Cheng-Lu ZhangYu-He Yuan
Dec 30, 2020·The Journal of Biological Chemistry·Emily H ClarkThomas Briston
Jan 31, 2020·Journal of Chemical Neuroanatomy·Sachchida Nand Rai, Payal Singh
Jan 8, 2021·The Journal of Biological Chemistry·Emily H ClarkThomas Briston
Jun 22, 2021·Frontiers in Molecular Neuroscience·Joseph KedraGeorge M Smith
Aug 28, 2021·Cells·Xufeng CenHongguang Xia

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
GTPases
ubiquitination

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.